Skip to content

Estimation of Alcohol, Substance and Cigarettes Exposure Among Pregnant Women in the Israeli Periphery and Center, and the Contribution of Brief Intervention

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01252706
Enrollment
10000
Registered
2010-12-03
Start date
2011-03-31
Completion date
2012-07-31
Last updated
2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

brief intervention, alcohol, nicotine, drug abuse

Brief summary

The aims is to evaluate the rate of exposure to alcohol, psychoactive substance and nicotine among pregnant women in periphery hospital (Poria) and in the center of Tel Aviv (Ichilov) and to evaluate study Brief Intervention impact on reduction exposure, and its effect on newborn outcomes.

Detailed description

All pregnant women who will arrive to Poria (and third of pregnant who will arrive to Ichilov) ER, high risk, and follow-up clinic will be asked for alcohol exposure, smoking and psychoactive substance usage. Relevant women will be asked to participate in a brief intervention treatment for about 30 min by expert personal, and a follow-up by phone every 3 months during pregnancy and post deliver. In addition, through all the year, questionnaires about exposure will be given to all women who will have labor (about 3000 labors), and third of 10,000 expecting in Ichilov. We expect in the second half of the year, to have those who enrolled to the BI. New-born outcome of the BI group as compared to the non-BI group will be compared, as well as rate of alcohol/substance/nicotine abstinence and reduction.

Interventions

BEHAVIORALbrief intervention

limit time giving information, motivation, empathy, responsibility, self control

Sponsors

Ministry of Health, Israel
CollaboratorOTHER_GOV
Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* pregnant women who smoke cigarets, drink alcohol and or abuse any drugs

Exclusion criteria

* pregnant women who do not smoke cigarets, drink alcohol and or abuse any drugs

Design outcomes

Primary

MeasureTime frameDescription
nicotine, alcohol and drug abstinenceduring pregnancy until labornicotine alcohol and drug abstinence will be evaluate during pregnancy until labor

Secondary

MeasureTime frameDescription
newborn weight of birthat labordata about newborn at labor and it relation to brief intervention of mother will be deternined

Countries

Israel

Contacts

Primary ContactAriel Many, MD
arielm@tasmc.health.gov.il972524266954
Backup ContactEinat Peles, Ph.D.
einatp@tasmc.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026